Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Hinge Health (HNGE) Research & Development (2024 - 2025)

Hinge Health's Research & Development history spans 2 years, with the latest figure at $32.8 million for Q4 2025.

  • For Q4 2025, Research & Development changed N/A year-over-year to $32.8 million; the TTM value through Dec 2025 reached $113.4 million, changed N/A, while the annual FY2025 figure was $368.1 million, 265.07% up from the prior year.
  • Research & Development for Q4 2025 was $32.8 million at Hinge Health, up from $31.9 million in the prior quarter.
  • Across five years, Research & Development topped out at $32.8 million in Q4 2025 and bottomed at $23.8 million in Q3 2024.